More Silicon Valley executives, even top brass, are using drugs on the job, a trend that puts general counsel and board members in an extraordinarily difficult spot, legal observers and academics say.

The Wall Street Journal recently documented the trend, saying Tesla CEO Elon Musk and Google co-founder Sergey Brin are among those who take psychedelics and similar substances, such as magic mushrooms, Ketamine and LSD. Many executives “microdose,” a quantity insufficient to produce a mind-bending hallucinatory effect, believing the drugs maximize mindfulness and are a gateway to business breakthroughs.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]